Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Stigma-Focused therapy ease eating disorders in LGBTQ+ individuals?

NCT ID NCT06565637

Symptom relief Sponsor: Auburn University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This early study tests a new therapy called PRIDE for sexual minority individuals (lesbian, gay, bisexual, etc.) who have an eating disorder. The therapy aims to reduce internalized stigma and improve coping with stress related to their identity. Thirty participants will attend up to 14 weekly therapy sessions and be followed for 6 months to see if their symptoms improve.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Promoting Resilience to Improve Disordered Eating (PRIDE) therapy
What this could lead to
If it works, this could point toward a tailored therapy that helps sexual minority individuals manage eating disorders by addressing stigma and stress.
What could go wrong
This is a very small, early-phase trial with only 30 participants. It may not show clear benefits, and the therapy may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age 18 to 65 years * identify as lesbian, gay, bisexual, other non-heterosexual identities * meet criteria for a Diagnostic and Statistical Manual - 5 (DSM-5) eating disorder (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, other specified feeding or eating disorder) * reports current (past 12 months) experience with discrimination due to sexual orientation; * speaks English * has internet access and a working webcam * reside (and plan to continue to reside for the study duration) in California or one of the Psychology Interjurisdictional Compact (PSYPACT) states * able to provide informed consent Exclusion Criteria: * inability to speak/read English * active suicidal plans or intent * other major untreated psychiatric diagnoses (e.g., untreated bipolar disorder, untreated psychosis) * body mass index below 17.0, a standard clinical cutoff used to denote moderate-severe underweight that may be indicated for a higher level of medical care than standard outpatient treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anorexia nervosa are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anorexia nervosa binge eating disorder bulimia nervosa eating disorder Feeding and Eating Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eating disorders Sexual minorities

Contacts and locations

Locations

  • Auburn University

    Auburn, Alabama, 36849-9027, United States

  • San Diego State University

    San Diego, California, 92182, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.